Study Title

Yttrium-90 Radiation Lobectomy: Dose Optimization and Prediction of FLR Hypertrophy to Enable Resection of HCC

Study Details

Description:

HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.

Contacts:

Robert Lewandowski, MD (Principal Investigator)

r-lewandowki@northwestern.edu

312-695-9121

Kristie Kennedy, MA

kristie.kennedy@northwestern.edu

312-695-4023

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468